OIG - Office of Inspector General
11/15/2024 | Press release | Distributed by Public on 11/15/2024 11:01
Pharmaceutical Company QOL Medical and CEO Agree to Pay $47M for Allegedly Paying Kickbacks to Induce Claims for QOL’s Drug Sucraid
Pharmaceutical Company QOL Medical and CEO Agree to Pay $47M for Allegedly Paying Kickbacks to Induce Claims for QOL's Drug Sucraid
Pharmaceutical company QOL Medical LLC (QOL) and its co-owner and CEO, Frederick E. Cooper, have agreed to pay $47 million to resolve allegations that they caused the submission of false claims to federal health care programs, in violation of the False Claims Act and similar state statutes, by offering kickbacks in the form of free Carbon-13 breath testing services to induce claims for QOL's drug Sucraid.
Action Details
- Date:November 15, 2024
- Agency:U.S. Department of Justice
-
Enforcement Types:
- Criminal and Civil Actions
Share